Developability

Streamlining Drug Development with Integrated In Silico and Laboratory Developability Assessments

Andrea Arsiccio, Ph.D.,; Eva Keilhauer, Ph.D.; Kristian Le Vay, Ph.D.

Coriolis Pharma

Down Stream Processing

Expediting Biologics Drug Development: Downstream Strategies to Accelerate Preclinical Development Timelines

Songyoung Kim

Samsung Biologics

Biologics Formulation

Successful Formulation Development for Biologics Using a Unique Biophysical Prediction and Screening Platform

Pawel Stanczak, Ph.D.

Tanvex CDMO

Translation

The Translational Index Score: Improving the Entire Drug Development Cycle

Jo Varshney, Ph.D., D.V.M.

Generative AI

Simplifying Target Discovery with an Artificial Intelligence Engine and Natural Language Chat

Petrina Kamya, Ph.D.

Insilico Medicine

Three Benefits of Using In Silico Technologies for Drug Discovery

Kimberly Brunner

Drug Design

Janssen, Iktos Collaborate on In Silico Drug Design

Emilie Branch

Pharma's Almanac